FDA Inspection 1316152 — SPIRAIR, INC.
The FDA completed an inspection of SPIRAIR, INC. on May 1, 2026 in South San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 1, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- South San Francisco, CA (United States)